(ethylenedinitrilo)-tetramethylenephosphonic acid has been researched along with Multiple Myeloma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bares, R; Dohmen, BM; Einsele, H; Kanz, L; Knop, S | 1 |
1 other study(ies) available for (ethylenedinitrilo)-tetramethylenephosphonic acid and Multiple Myeloma
| Article | Year |
|---|---|
153 Samarium-EDTMP in myeloablative dosage followed by a second autotransplantation in patients with relapsed multiple myeloma.
Topics: Fatal Outcome; Graft Survival; Humans; Male; Melphalan; Multiple Myeloma; Organometallic Compounds; Organophosphorus Compounds; Osteolysis; Peripheral Blood Stem Cell Transplantation; Radioisotopes; Radiopharmaceuticals; Salvage Therapy; Samarium; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2004 |